Christopher Fuglesang Mirati Therapeutics, Inc
As of March 9, 2021
Christopher Fuglesang Net Worth
- Net worth is estimated to be at least $379.81M
- Owns at least 2,000,000 units of Mirati Therapeutics, Inc stock
- Sold an estimated value of $153.26M in the last 4 years at Mirati Therapeutics, Inc
Christopher Fuglesang Trading
- Largest purchase of shares was 286,163 units , worth over $1.6M on January 10, 2017
- Largest sale of shares was 400,003 units , worth over $80.8M on October 30, 2020
- In total has made about 4 transactions over 4 years
- Usually trades in October, with the busiest year in 2017
Boxer Capital LLC, Boxer Asset Management Inc, JOSEPH LEWIS, MVA Investors LLC, Aaron Davis, IVAN LIEBERBURG, Bharatha Shehan Dissanayake, Christopher Fuglesang
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Christopher Fuglesang Mailing Address
- Mailing address is 11682 el Camino Real, Suite 320 San Diego CA 92130 CA
Mirati Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Charles M. Baum, M.D., Ph.D. | 2020 | $615,013 | $6,092,158 | $498,161 | $498,161 | $14,250 | $11,747,582 |
| Charles M. Baum, M.D., Ph.D. | 2019 | $597,100 | $7,474,287 | $410,506 | $410,506 | $2,500 | $8,484,393 |
| Charles M. Baum, M.D., Ph.D. | 2018 | $579,700 | $3,851,079 | $434,800 | $434,800 | $2,500 | $4,868,079 |
| James Christensen, Ph.D. | 2020 | $500,000 | $2,379,745 | $303,750 | $303,750 | $16,301 | $6,988,546 |
| James Christensen, Ph.D. | 2019 | $435,000 | $2,637,984 | $217,500 | $217,500 | $2,500 | $3,292,984 |
| James Christensen, Ph.D. | 2018 | $374,385 | $2,571,375 | $247,200 | $247,200 | $2,500 | $3,195,460 |
| Daniel Faga | 2020 | $494,231 | $4,999,987 | $303,750 | $303,750 | $362,373 | $9,160,360 |
| Benjamin Hickey | 2020 | $484,346 | $2,499,988 | $297,675 | $297,675 | $16,296 | $5,798,359 |
| Jamie A. Donadio | 2020 | $1,439 | $ | $ | $ | $422,122 | $423,561 |
| Jamie A. Donadio | 2019 | $373,900 | $2,637,984 | $186,950 | $186,950 | $2,500 | $3,201,334 |
| Jamie A. Donadio | 2018 | $363,000 | $1,040,832 | $217,800 | $217,800 | $2,500 | $1,624,132 |
| Isan Chen, M.D. | 2020 | $198,676 | $ | $ | $ | $485,281 | $683,957 |
| Isan Chen, M.D. | 2019 | $433,100 | $2,637,984 | $216,550 | $216,550 | $2,500 | $3,290,134 |
| Isan Chen, M.D. | 2018 | $420,500 | $1,040,832 | $252,300 | $252,300 | $2,500 | $1,716,132 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828021007114/mirati2021proxy.htm
Mirati Therapeutics, Inc Insider Trading
- The most recent transaction was 11,000 units sold on February 14, 2022 by Henry Fuchs worth over $1.16M
- In the last 9 years, insiders at Mirati Therapeutics, Inc sold an estimated value of $606.26M and bought an estimated value of $131.21M
- The most active traders are Charles Baum, PresidentFounder,Head R&D, Jamie Christensen, EVP, and Braslyn Ltd
- Insider trading is most common in January, with the busiest year in 2019
Mirati Therapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||